Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Enhanced Axonal Metabolism during Early Natalizumab Treatment in Relapsing-Remitting Multiple Sclerosis.
Characteristic cerebrospinal fluid cytokine/chemokine profiles in neuromyelitis optica, relapsing remitting or primary progressive multiple sclerosis.
CD44 is required for the migration of transplanted oligodendrocyte progenitor cells to focal inflammatory demyelinating lesions in the spinal cord.
A hematopoietic contribution to microhemorrhage formation during antiviral CD8 T cell-initiated blood-brain barrier disruption.
Short and long term variation in ultraviolet radiation and multiple sclerosis.
Biomarkers for multiple sclerosis.
FDA Approves First Drug for Lou Gehrig's Disease
Complex molecular and functional outcomes of single versus sequential cytokine stimulation of rat microglia.
Alemtuzumab 3-year data show durable effect on MS disability
Neurologic complications in patients with inflammatory bowel disease: Increasing relevance in the era of biologics.
Compositional Changes of B and T Cell Subtypes during Fingolimod Treatment in Multiple Sclerosis Patients: A 12-Month Follow-Up Study.
Genetic and epigenetic fine mapping of causal autoimmune disease variants.
Speedy eye movements in multiple sclerosis: Association with performance on visual and nonvisual cognitive tests.
The occurrence of dystonia in upper-limb multiple sclerosis tremor.
Adult neural precursor cells from the subventricular zone contribute significantly to oligodendrocyte regeneration and remyelination.
Hormone and immune system interactions in demyelinating disease.
[Biosimilar of interferon-beta 1b in the treatment of multiple sclerosis and the own experience in the use of ronbetal.]
T Cell-Intrinsic Function of the Noncanonical NF-κB Pathway in the Regulation of GM-CSF Expression and Experimental Autoimmune Encephalomyelitis Pathogenesis.
Re-engineering of pathogenic aquaporin 4-specific antibodies as molecular decoys to treat neuromyelitis optica.
Impact of Depression, Fatigue and Disability on Quality of Life in Chinese Patients with Multiple Sclerosis.
Potential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection.
Patient's Perspective: Hard Lessons from a Long Hospital Stay.
Transgenic inhibition of astroglial NF-kappaB protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis.
Redox regulation of NF-κB p50 and M1 polarization in microglia.
Different mechanisms underlying changes in excitability of peripheral nerve sensory and motor axons in multiple sclerosis.
Pages
« first
‹ previous
…
201
202
203
204
205
206
207
208
209
…
next ›
last »